A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers

被引:103
作者
Schrenk, D
Brockmeier, D
Morike, K
Bock, KW
Eichelbaum, M
机构
[1] Univ Tubingen, Inst Toxicol, D-72074 Tubingen, Germany
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70341 Stuttgart, Germany
[3] Hoechst AG, Sect Biometry, Clin Res Dept H840, D-65926 Frankfurt, Germany
关键词
caffeine metabolism; cigarette smokers;
D O I
10.1007/s002280050394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. To analyse distributions of a urinary ratio of caffeine metabolites (MRc) representative of cytochrome P450 (CYP) 1A2 activity in a cohort of Caucasian German healthy volunteers and to re-assess the effects of smoking and oral contraceptives on the range and type of MRc distribution. Methods: A cohort of volunteers comprising 192 individuals (96 males, 96 females) was divided into subgroups according to smoking and/or use of oral contraceptives. The CYP1A2 substrate caffeine was administered, and urine was collected for 6h and analysed for representative caffeine metabolites. Distribution of a CYP1A2-dependent MRc was analysed using cumulative distribution (probit) plots and Rosin-Rammler-Sperling-Weibull (RRSW) functions. Results: Cumulative distribution curves for males, and females, without further subgrouping for smoking habits and/or oral contraceptive steroid (OCS) consumption, showed slightly higher MRc values, i.e. slightly higher CYP1A2 activities, in males. Significantly higher MRc values were found in smokers of both sexes than in nonsmokers. The distributions among female non-smokers or smokers with and without OCS were nearly super-imposible, however. For the two male subgroups, the sum of two RRSW functions resulted in a better adjustment to the data than a unimodal skewed distribution. A weak correlation between MRc and the number of cigarettes smoked per day was found. Conclusion: The inducing effect of smoking on CYP1A2 activity was confirmed, whereas no significant inhibitory effect of oral contraceptives was observed. The finding that the data are compatible with bimodal distributions in non-smokers suggests a significant impact of genetic factors on MRc. Among smokers, data were also compatible with bimodal distributions, i.e. with the existence of a "non-responder" phenotype concerning CYP1A2 induction by compounds present in tobacco smoke.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 41 条
[1]   IMPAIRMENT OF CAFFEINE CLEARANCE BY CHRONIC USE OF LOW-DOSE ESTROGEN-CONTAINING ORAL-CONTRACEPTIVES [J].
ABERNETHY, DR ;
TODD, EL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (04) :425-428
[2]   THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, AND PARACETAMOL AS PROBES [J].
BOCK, KW ;
SCHRENK, D ;
FORSTER, A ;
GRIESE, EU ;
MORIKE, K ;
BROCKMEIER, D ;
EICHELBAUM, M .
PHARMACOGENETICS, 1994, 4 (04) :209-218
[3]  
BROCKMEIER D, 1991, HOEGIP PC INTERACTIV
[4]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[5]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[6]  
CATTEAU A, 1995, EUR J CLIN PHARMACOL, V47, P423
[7]   THE CONTRIBUTION OF GENETICALLY-DETERMINED OXIDATION STATUS TO INTERINDIVIDUAL VARIATION IN PHENACETIN DISPOSITION [J].
DEVONSHIRE, HW ;
KONG, I ;
COOPER, M ;
SLOAN, TP ;
IDLE, JR ;
SMITH, RL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :157-166
[8]   THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS [J].
EICHELBAUM, M ;
GROSS, AS .
PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :377-394
[9]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[10]   IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR [J].
FERNANDEZSALGUERO, P ;
PINEAU, T ;
HILBERT, DM ;
MCPHAIL, T ;
LEE, SST ;
KIMURA, S ;
NEBERT, DW ;
RUDIKOFF, S ;
WARD, JM ;
GONZALEZ, FJ .
SCIENCE, 1995, 268 (5211) :722-726